To further characterize the IgA deposits found in glomeruli of patients with IgA nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus, renal biopsies from patients with these disorders were stained by immunofluorescence with monoclonal antiIgA subclass reagents, anti-light chain reagents and anti-J chain. The mesangium and peripheral capillary were brightly stained for IgA1 and were negative for IgA2. IgA1 and, to a lesser extent, IgA2 were contained in tubular casts. Both kappa and lambda light chains were found in all deposits. The intensity of J chain staining correlated with the intensity of IgM and not IgA staining. Biopsies brightly stained for IgA but negative for IgM were negative for J chain. These results indicate that glomerular IgA deposits in these disorders consist predominantly of monomers of IgA1.
INTRODUCTION
IgA nephropathy is characterized by IgA deposits in the renal mesangium and recurring episodes of hematuria (1) (2) (3) . It occurs most frequently in adolescent boys and young men (2) and is frequently preceeded by an episode of upper respiratory or gastrointestinal infection of presumed viral etiology (1, 3) .
Deposition of IgA within the glomerulus has also been observed in patients with systemic lupus erythematosus (SLE)l (4), liver disease (5) , and anaphylactoid or Henoch-Schonlein purpura (HSP) nephritis 1432 (6) . The latter disorder is also more commonly observed in males and is frequently preceeded by a viral infection (7) . The mechanism(s) responsible for the deposition of IgA in these disorders is unclear. IgA immune complexes have been found in the serum of patients with HSP (8) and elevated levels of IgA have been noted in the serum of patients with HSP (9) and IgA nephropathy (3) . The antigenic specificity of this IgA is unknown. When the IgA was eluted from kidneys of four patients with IgA nephropathy, one eluate showed weak binding of intraglomerular components of a normal kidney, the other three failed to bind (2) .
The presence of glomerular deposits of properdin (10) Antibodies. Monoclonal hybridoma anti-IgA subclass antibodies were prepared by described methods (13) . Briefly, lymphocytes from the lymph nodes of mice immliunized with purified IgA myelomas were fused to tumor cells from the HAT sensitive, nonproducing myeloma line P63xAg8653 (14) . IgA subclass specific hybridomas were detected by an enzymelinked immunoadsorbent assay. The anti-IgA1, designated clone 1-155-1, is a mouse y3X of BALB/c allotype. The antiIgA2, designated as 14-3-26, is a mouse y2BK of A/J allotype. These monoclonal antibodies have been shown to be IgA subclass specific by several techni(lues. In an enzymelinked immunoabsorbent assay on 37 IgA myelomias, 30 IgA, and 7 IgA2 including both Am2+ and Am2-allotypes, the monoclonal hybridoma antibodies recognized only the appropriate subclass. In a direct binding radioimmunoassay the antibodies can detect as little as 1 ng/ml of the IgA subclass. This binding is not inhibited by as much as 100 ,ug/ml of IgG or 10 ,ug/ml of IgM. By indirect immllunofluorescent staining, the anti-IgA, 1-155-1, stained plasmiia cells from a patient with IgA, myelomiia but not those from a patient with IgA2 myeloma. The reverse was true vith the anti-IgA2, 14-3-26.
Rhodaminie-tagged goat anti-miiouse y2B and y3 were a gift from Dr. J. F. Kearney, Birminghamii, Ala. These goat antimouse reagents do not staini normiial or abnormal renal tisslue in the absence of mouse aniti-humiiani antibodies. The rhodaminetagged rabbit anti-J chaini was a gift from Dr. J. Mestecky, Birmingham, Alabama. Fluoresceini isothiocyanate conjugated anti-human IgA, IgM, kappa chain and lambda chain were purchased from Meloy Laboratories, Inc., (Springfield, Va.). The anti-IgA and IgM vere al)sorbed with IgG before use to insure lack of reactivity with light chains. These antisera were shown to be heavy chain specific by reactivity with the appropriate antigen in gel diffusion and by immunohistochemiiical studies on kidney tissue.
Imml1tlunofluorescentce studies. Tissue was obtained by percutaneous or open kidney biopsy, snap frozen in isopentane precooled in liquid nitrogen, and stored at -70°C. Sections (4 ,uM) were fixed to slides with acetone and washed three times in phosphate-buffered isotonic saline before immunofluorescent staining. The intestinal tissue, the tonsil, and the 19 renal biopsies that had beeni obtained more than 6 mo earlier were resectioned. The intensity of the staining and the background staining on these stored tissues were indistinguishable from that obtained with fresh tissue.
Indirect immunofluorescent staining was used to detect the IgA subelasses. The hybridomas antibody was layered over the tissue and allowed to incubate for 20 min at room temperature and the slides were then washed twice in phosphatebuffered isotonic saline. The slides incubated with 1-155-1, the mouse y3X anti-human IgA1, were then stained with rhodamine-tagged goat anti-mouse y3. Those incubated with 14-3-26, the mouse y2BK anti-human IgA2, were stained with rhodamine-tagged goat anti-mouse y2B. Tissues were directly IgA Subclass-specific Deposits in Glomerulonephropathies stained with fluorochrome-tagged anti-IgA, IgM, kappa, lambda, or J chain. To enhance J chain staining some slides stained with the rhodamine-tagged rabbit anti-human J chain were counterstained with fluorescein-tagged goat anti-rabbit IgG. Slides were mounted under a coverslip and examined with a Zeiss fluorescent microscope (Carl Zeiss, Inc., New York) with epi-illumination and appropriate exciter and absorbing filters. All slides were read by two investigators.
RESULTS
The glomerular mesangium in renal biopsies from all patients with IgA nephropathy or HSP nephritis stained brightly for IgA (Table I) Because the IgA in glomerular deposits was exclusively of the IgA, subclass, biopsies were stained with anti-kappa and anti-lambda antibodies to determine whether the IgA was monoclonal in origin. Glomerular deposits in biopsies from four patients with IgA nephropathy and four patients with HSP could be stained with both anti-kappa and anti-lambda. In four cases the lambda staining was brighter; in the remaining four the intensity of staining was equivalent using either reagent. To detect the presence of IgA dimers in glomeruli of patients with IgA deposits, renal biopsies were stained with rabbit anti-human J chain. Because J chain is also a component of IgM and IgM is frequently found in association with IgA in these glomerular deposits, the intensity of J chain staining was correlated with the intensity of IgM staining and IgA staining. J chain could be detected in glomeruli of patients with IgA nephropathy but the intensity of staining correlated closely with that of IgM and not IgA. J chain was not detected in two biopsies with intense (3+) mesangial staining for IgA and either no or trace staining for IgM (Fig. 1) . (16) .
DISCUSSION
Recent studies have also shown that charge may influence the location of renal immune complex deposition. In the rat, cationic complexes were found in the renal mesangium, whereas anionic complexes localized to the capillary walls (17) . However, there are only small charge differences between IgA, and IgA2 making this an unlikely differentiating mechanism.
Past studies characterizing the IgA deposits in IgA nephropathy and HSP have shown that secretory component cannot be found in the glomerular lesions (18) . This report provides further evidence that the IgA in these deposits does not reflect the IgA produced at the mucosal surfaces for transport into secretions under normal circumstances. The pathologic mechanisms that result in the selective deposition of monomers of IgA, in the renal mesangium remain unknown.
